Aurora Cannabis (ACB) EBIT Margin (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly EBIT Margin of 3.51% for Q1 2026, up 2532.0% year-over-year from 0.13% in Q1 2025, and down 79.26% quarter-over-quarter from 16.92% in Q4 2025.
Aurora Cannabis (ACB) EBIT Margin (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported EBIT Margin for 10 consecutive years, with 3.51% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBIT Margin rose 2532.0% year-over-year to 3.51%; the TTM figure through Mar 2026 stood at 6.17% (up 464.0% YoY), while the FY2026 annual figure was 14.55%, down 1627.0% from the prior year.
- EBIT Margin declined to 3.51% in Q1 2026 per ACB's latest filing, from 16.92% in the prior quarter.
- Across five years, EBIT Margin topped out at 41.79% in Q4 2024 and bottomed at 1043.86% in Q2 2023.
- Historically, EBIT Margin has averaged 94.82% across 5 years, with a median of 2.64% in 2023.
- Annual changes were most pronounced in 2023 — EBIT Margin sank 92397 bps — and 2024, when it soared 104350 bps.
- Aurora Cannabis' EBIT Margin stood at 109.42% in 2022, then surged by 75 bps to 27.33% in 2023, then surged by 253 bps to 41.79% in 2024, then slumped by 60 bps to 16.92% in 2025, then sank by 79 bps to 3.51% in 2026.
- Business Quant data shows ACB's EBIT Margin at 3.51% in Q1 2026, 16.92% in Q4 2025, and 4.34% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Aurora Cannabis | 232.22 Mn | 159.91 Mn | 25.75 Mn | 14.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.51% |
| Dec 31, 2025 | 16.92% |
| Sep 30, 2025 | 4.34% |
| Jun 30, 2025 | -1.54% |
| Mar 31, 2025 | -21.81% |
| Dec 31, 2024 | 41.79% |
| Sep 30, 2024 | -1.36% |
| Jun 30, 2024 | -0.36% |
| Mar 31, 2024 | -3.35% |
| Dec 31, 2023 | -27.33% |
| Sep 30, 2023 | -1.93% |
| Jun 30, 2023 | -1,043.86% |
| Dec 31, 2022 | -109.42% |
| Sep 30, 2022 | -109.31% |
| Jun 30, 2022 | -119.89% |
| Mar 31, 2022 | -143.52% |
| Dec 31, 2021 | -92.09% |
| Sep 30, 2021 | -65.51% |
| Jun 30, 2021 | 26.75% |
| Mar 31, 2021 | -259.16% |